Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DANTROLENE SODIUM 100 MG CAP

dantrolene sodium
$0.7707per EA

Strength

100 mg/1

Manufacturer

Elite Laboratories, Inc.

NDC

64850084201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DANTROLENE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA076686

On Market Since

10/26/2005

Pharmacological Classes

Decreased Striated Muscle Contraction
Decreased Striated Muscle Tone
Skeletal Muscle Relaxant

Price History

1W

0.0%

1M

+1.4%

3M

+2.2%

6M

-10.1%

1Y

-22.6%

3Y

N/A

5Y

N/A

All

-37.9%

Generic Alternatives

1 alternative • Same active ingredient

DANTROLENE SODIUM 100 MG CAP
Generic
49884036401•Endo USA Inc.
$0.7707

Related Drugs

Same classification

DANTROLENE SODIUM 25 MG CAP
Generic
00115441101•Amneal Pharmaceuticals of New York LLC
$0.4209
per EA
DANTROLENE SODIUM 25 MG CAP
Generic
00904721104•Major Pharmaceuticals
$0.4209
per EA
DANTROLENE SODIUM 25 MG CAP
Generic
50268021715•AvPAK
$0.4209
per EA
DANTROLENE SODIUM 25 MG CAP
Generic
68084030021•American Health Packaging
$0.4209
per EA
DANTROLENE SODIUM 50 MG CAP
Generic
00115442201•Amneal Pharmaceuticals of New York LLC
$0.6226
per EA
DANTROLENE SODIUM 25 MG CAP
Generic
00115441103•Amneal Pharmaceuticals of New York LLC
$0.7194
per EA
DANTROLENE SODIUM 100 MG CAP
Generic
00115443301•Amneal Pharmaceuticals of New York LLC
$0.7707
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy